Exchange Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Exchange Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-63	Closed	-$15K	–	256
2018 Q3	$15K	Hold	63	–	–	﹤0.01%	217
2018 Q2	$13K	Hold	63	–	–	﹤0.01%	210
2018 Q1	$13K	Buy	63 +21	+50%	+$4.41K	﹤0.01%	190
2017 Q4	$8K	Sell	42 -110	-72%	-$21.1K	﹤0.01%	188
2017 Q3	$29K	Buy	152 +110	+262%	+$19.9K	0.01%	164
2017 Q2	$7K	Buy	+42	New	+$7.05K	﹤0.01%	195
2015 Q1	–	Sell	-26	Closed	-$3K	–	291
2014 Q4	$3K	Buy	+26	New	+$3.16K	﹤0.01%	252

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exchange Capital Management's TMO Position: Q4 2018 in Review

Exchange Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2018, closing a stake of 63 shares — an estimated $15K sold.

Exchange Capital Management first reported a position in TMO in Q4 2014 and held it in 7 quarters. The position peaked at $29K in Q3 2017. 1,457 funds tracked by Wall St. Rank hold TMO as of Q4 2018.

Exchange Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2018 after selling out during the quarter.
Exchange Capital Management sold 63 Thermo Fisher Scientific shares in Q4 2018, an estimated $15K.
Exchange Capital Management first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 7 quarters.
Exchange Capital Management's Thermo Fisher Scientific position peaked at $29K in Q3 2017.
1,457 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2018.

Based on Exchange Capital Management's 13F filing for Q4 2018, filed 1 Feb 2019.